Markets:

Overview

News

Currencies

International

Treasuries

KALA BIO, Inc. - Common Stock (NQ:KALA)

0.1702 +0.0072 (+4.42%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about KALA BIO, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Looking Into Kala Pharmaceuticals's Return On Capital Employed ↗

September 06, 2022

According to data from Benzinga Pro, during Q2, Kala Pharmaceuticals's (NASDAQ:KALA) reported sales totaled $2.10 million. Despite a 14.66% increase in earnings, the company posted a loss of $28.11...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 06, 2022

Via Benzinga

Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday ↗

September 01, 2022

Gainers

Via Benzinga

Recap: Kala Pharmaceuticals Q2 Earnings ↗

August 11, 2022

Kala Pharmaceuticals (NASDAQ:KALA) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Recap: Kala Pharmaceuticals Q1 Earnings ↗

May 16, 2022

Kala Pharmaceuticals (NASDAQ:KALA) reported its Q1 earnings results on Monday, May 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session ↗

August 31, 2022

Gainers Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 31, 2022

Via Benzinga

Earnings Scheduled For May 16, 2022 ↗

May 16, 2022

Companies Reporting Before The Bell • AcelRx Pharmaceuticals (NASDAQ:ACRX) is estimated to report quarterly loss at $0.06 per share on revenue of $550.00 thousand.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 31, 2022

It's time for another breakdown of the biggest pre-market stock movers and the news that's moving those shares on Wednesday!

Via InvestorPlace

Why Cepton Is Trading Higher By 19%; Here Are 28 Stocks Moving Premarket ↗

August 31, 2022

Gainers Software Acquisition Group Inc. III (NASDAQ: NOGN) shares rose 80.1% to $6.04 in pre-market trading after dropping over 65% on Tuesday.

Via Benzinga

Alcon Buys Aerie Pharma For $770M To Enhance Its Ophthalmic Pharma Portfolio ↗

August 23, 2022

Via Benzinga

Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket ↗

August 22, 2022

Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated public...

Via Benzinga

CVS Health To $120? Here Are 5 Other Price Target Changes For Monday ↗

August 15, 2022

Mizuho raised the price target on CVS Health Corporation (NYSE: CVS) from $115 to $120. Mizuho analyst Ann Hynes maintained the stock with a Buy rating. CVS Health shares fell 0.4% to $106.00 in...

Via Benzinga

Kala Pharma Stops Working On Certain Preclinical Programs, Extends Cash Runway Into 2024 ↗

August 11, 2022

Kala Pharmaceuticals Inc (NASDAQ: KALA) said it would focus its efforts on KPI-012, mesenchymal stem cell secretome (MSC-S), for rare and severe ocular diseases.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

August 11, 2022

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 30, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

May 31, 2022

On Tuesday, 36 companies achieved new lows for the year.

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

May 26, 2022

Good morning! We're starting off another day of trading with an overview of the biggest pre-market stock movers for Thursday!

Via InvestorPlace

88 Biggest Movers From Yesterday ↗

May 26, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 25, 2022

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

May 25, 2022

Rise and shine, traders! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 24, 2022

Via Benzinga

Why Kala Pharmaceuticals Shares Are Rising Today ↗

May 23, 2022

Kala Pharmaceuticals Inc (NASDAQ: KALA) shares are trading higher after the company said it would sell its EYSUVIS and INVELTYS treatments for $60 million.

Via Benzinga

71 Biggest Movers From Yesterday ↗

May 25, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) shares surged 100% to close at $1.18 on Tuesday after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7...

Via Benzinga

This Biopharma Stock Surges After Offloading Its Ophthalmic Eye Drop Portfolio ↗

May 23, 2022

Via Benzinga

50 Stocks Moving In Tuesday's Mid-Day Session ↗

May 24, 2022

Gainers CynergisTek, Inc. (NYSE: CTEK) jumped 100% to $1.18 after the company entered into a definitive agreement to be acquired by Clearwater Compliance for roughly $17.7 million.

Via Benzinga

What 4 Analyst Ratings Have To Say About Kala Pharmaceuticals ↗

May 17, 2022

Kala Pharmaceuticals (NASDAQ:KALA) has observed the following analyst ratings within the last quarter:

Via Benzinga

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More ↗

May 16, 2022

Biopharma stocks remained largely unchanged in the week ending May 13, with the defensive nature of the sector coming to its aid. Stocks reacted to the broader market move and earnings news from...

Via Benzinga

Earnings Preview For Kala Pharmaceuticals ↗

May 13, 2022

Kala Pharmaceuticals (NASDAQ:KALA) is set to give its latest quarterly earnings report on Monday, 2022-05-16. Here's what investors need to know before the announcement. Analysts estimate that Kala...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

KALA BIO, Inc. - Common Stock (NQ:KALA)

All News about KALA BIO, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today